Thomas’ Hematopoietic Cell Transplantation 2015
DOI: 10.1002/9781118416426.ch22
|View full text |Cite
|
Sign up to set email alerts
|

Radiotherapeutic Principles of Hematopoietic Cell Transplantation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 149 publications
0
1
0
Order By: Relevance
“…Even when TBI is fractionated and given concurrently with chemotherapy, pneumonitis occurs in about 25% of patients, although fractionation clearly reduces the risk of fatal events. Other acute toxic effects of TBI include parotitis (generally occurring on the second day of treatment) (34,35), nausea and vomiting (which can be prevented with modern anti-emetic agents), dry mouth and mucositis (which typically appear 5-20 days after TBI), diarrhea, fatigue, decreased appetite, erythema, esophagitis, and alopecia (36). Single-dose nonmyeloablative TBI (2 Gy) seems to not be associated with significant acute side effects and is well tolerated (37).…”
Section: Toxicity and Follow-upmentioning
confidence: 99%
“…Even when TBI is fractionated and given concurrently with chemotherapy, pneumonitis occurs in about 25% of patients, although fractionation clearly reduces the risk of fatal events. Other acute toxic effects of TBI include parotitis (generally occurring on the second day of treatment) (34,35), nausea and vomiting (which can be prevented with modern anti-emetic agents), dry mouth and mucositis (which typically appear 5-20 days after TBI), diarrhea, fatigue, decreased appetite, erythema, esophagitis, and alopecia (36). Single-dose nonmyeloablative TBI (2 Gy) seems to not be associated with significant acute side effects and is well tolerated (37).…”
Section: Toxicity and Follow-upmentioning
confidence: 99%